Five years after AlphaFold 2's debut, Google DeepMind’s protein‑structure AI has become a standard research tool in biochemistry and biology training programs, the company’s scientists say. AlphaFold models now underpin drug‑discovery workflows, speed structural biology research, and are integrated into graduate-level curricula, according to interviews with DeepMind researchers including John Jumper and Pushmeet Kohli. The technology’s academic uptake—cited in the Fortune coverage—shows how AI can move from breakthrough to routine lab infrastructure and reshape research training and grant expectations.